161 related articles for article (PubMed ID: 19548034)
1. Involvement of nigrostriatal pathway in Japanese encephalitis with movement disorders: evidence from 99mTc-TRODAT-1 and 123I-IBZM SPECT imagings.
Liao CH; Ling Z; Chou CH; Huang WS; Denq JC; Lin JC; Chen CY; Chang CJ; Peng GS
Mol Imaging Biol; 2010; 12(1):9-14. PubMed ID: 19548034
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features.
Wu YC; Peng GS; Cheng CA; Lin CC; Huang WS; Hsueh CJ; Lee JT
Ann Nucl Med; 2009 Jun; 23(4):409-12. PubMed ID: 19381760
[TBL] [Abstract][Full Text] [Related]
3. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.
Ma KH; Huang WS; Chen CH; Lin SZ; Wey SP; Ting G; Wang SD; Liu HW; Liu JC
Nucl Med Biol; 2002 Jul; 29(5):561-7. PubMed ID: 12088726
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.
Kao PF; Wey SP; Yang AS
Kaohsiung J Med Sci; 2009 Nov; 25(11):601-7. PubMed ID: 19858039
[TBL] [Abstract][Full Text] [Related]
5. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
Hwang WJ; Yao WJ; Fu YK; Yang AS
Psychiatry Res; 2008 Feb; 162(2):159-66. PubMed ID: 18248965
[TBL] [Abstract][Full Text] [Related]
6. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Hwang WJ; Yao WJ
J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
[TBL] [Abstract][Full Text] [Related]
7. A Japanese Encephalitis Patient Presenting with Parkinsonism with Corresponding Laterality of Magnetic Resonance and Dopamine Transporter Imaging Findings.
Tadokoro K; Ohta Y; Sato K; Maeki T; Sasaki R; Takahashi Y; Shang J; Takemoto M; Hishikawa N; Yamashita T; Lim CK; Tajima S; Abe K
Intern Med; 2018 Aug; 57(15):2243-2246. PubMed ID: 29526949
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
9. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
[TBL] [Abstract][Full Text] [Related]
10. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
Hwang WJ; Yao WJ; Wey SP; Ting G
Eur Neurol; 2004; 51(1):26-9. PubMed ID: 14631126
[TBL] [Abstract][Full Text] [Related]
11. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
12. Early white matter injuries associated with dopamine transporter dysfunction in patients with acute CO intoxication: A diffusion kurtosis imaging and Tc-99m TRODAT-1 SPECT study.
Chou MC; Lai PH; Li JY
Eur Radiol; 2019 Mar; 29(3):1375-1383. PubMed ID: 30143836
[TBL] [Abstract][Full Text] [Related]
13. A phase 2, open-label, multi-center study to evaluate the efficacy and safety of
Sun Y; Liu C; Chen Z; Li B; Lv Z; Lou J; Tang J; Wang Y; Zhang G; Liu X
Ann Nucl Med; 2020 Jan; 34(1):31-37. PubMed ID: 31646428
[TBL] [Abstract][Full Text] [Related]
14. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6.
Kim JM; Lee JY; Kim HJ; Kim JS; Kim YK; Park SS; Kim SE; Jeon BS
J Neurol Neurosurg Psychiatry; 2010 May; 81(5):529-32. PubMed ID: 20460591
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter binding in Wilson's disease.
Huang CC; Chu NS; Yen TC; Wai YY; Lu CS
Can J Neurol Sci; 2003 May; 30(2):163-7. PubMed ID: 12774959
[TBL] [Abstract][Full Text] [Related]
18. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
[TBL] [Abstract][Full Text] [Related]
19. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
Verstappen CC; Bloem BR; Haaxma CA; Oyen WJ; Horstink MW
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):502-7. PubMed ID: 17053905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
